TELEhealth Shared decision-making COaching for lung cancer screening in Primary carE (TELESCOPE).
Our primary objective is to compare the effectiveness of the TELESCOPE intervention vs. enhanced usual care (EUC) on shared decision making (SDM) for lung cancer screening.
Secondary objectives are to test the effectiveness of the TELESCOPE intervention vs. EUC on screening uptake, adherence with diagnostic testing and annual testing, and smoking cessation referrals and receipt of tobacco treatment for current smokers. We will also use a mixed methods approach to evaluate the implementation potential of navigator-led decision coaching for LCS and identify components and organizational and individual level characteristics that might facilitate or interfere with successful implementation.
- RWJBarnabas Health
- Robert Wood Johnson University Hospital, Somerset
- Rutgers University
Inclusion Criteria: - Inclusion Criteria Cluster Randomized Trial (N=420) Eligibility of patients for the cluster randomized trial will follow United States Preventive Services Task Force criteria for lung cancer screening. Specifically, patients must: - Be 50 to 77 years of age - Be a current or former smoker having quit within the past 15 years - Have at least a 20 pack-year smoking history - Be scheduled for a non-acute care visit at one of the study sites. Interviews (N=50) Participants completing the semi-structured interviews will be: - A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator (n=20) at one of the participating sites or a TELESCOPE study patient navigator (n=7) and nurse navigator (n = 3) - Age 18 or older - Fluent in English Online surveys (N=130) Providers completing online PRISM construct surveys will be: - A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator - Age 18 or older - Fluent in English Exclusion Criteria: - Cluster Randomized Trial (N=420) Excluded will be patients who: - Do not speak English - Have a history lung cancer - Were screened for lung cancer within the past 12 months - Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider - Are unable to provide informed consent Interviews (N=50) Providers/administrators will be excluded if they: - Are unable to provide informed consent Online surveys (N=130) - Are unable to provide informed consent - Women who are pregnant. English proficiency is required for the completion of surveys, and the intervention will be conducted in English.
Please note that we have obtained the inclusion and exclusion criteria information from the National Institutes of Health’s clinical trials web site ClinicalTrials.gov. The listed criteria may not necessarily reflect recent amendments to the protocol and the current criteria.
For further information about clinical trials, please contact us at 732-235-7356.